Quick Comparison
| Phenibut | Zinc | |
|---|---|---|
| Half-Life | 5-6 hours | Tissue zinc turns over over weeks |
| Typical Dosage | Standard: 250-1000 mg on an empty stomach, no more than 1-2 times per week. NEVER use daily — tolerance and dependence develop within 3-5 days of consecutive use. Onset: 2-4 hours (slow). Do not exceed 2000 mg per occasion. | Standard: 15-30 mg elemental zinc daily. Do not exceed 40 mg daily long-term (can cause copper depletion). Zinc picolinate, zinc bisglycinate, and zinc carnosine are well-absorbed forms. Zinc oxide is poorly absorbed. Take with food to reduce nausea. If supplementing >15 mg daily, add 1-2 mg copper. |
| Administration | Oral (powder, capsules). Take on an empty stomach — food significantly reduces absorption. Slow onset (2-4 hours). | Oral (capsules, tablets, lozenges). Take with food. Zinc picolinate or bisglycinate for best absorption. |
| Research Papers | 10 papers | 9 papers |
| Categories |
Mechanism of Action
Phenibut
Phenibut is a structural analog of GABA with a phenyl ring that confers lipophilicity and allows blood-brain barrier penetration (unlike GABA itself). It acts as a GABA-B receptor agonist, binding to the GABAB1/GABAB2 heterodimer and activating Gi/o-coupled signaling (similar to baclofen), producing anxiolytic, muscle relaxant, and sedative effects through inhibition of adenylyl cyclase and modulation of potassium and calcium channels. Phenibut also blocks the alpha-2-delta-1 and alpha-2-delta-2 subunits of voltage-gated calcium channels, reducing presynaptic calcium influx and neurotransmitter release (similar to gabapentin/pregabalin). The dual mechanism—GABA-B agonism dampening inhibitory interneurons and calcium channel blockade reducing excitatory transmission—produces potent anti-anxiety and sleep-promoting effects. Rapid tolerance develops due to receptor downregulation.
Zinc
Zinc is released from synaptic vesicles (via ZnT3 transporter) during neurotransmission from glutamatergic mossy fiber and Schaffer collateral terminals. It modulates NMDA receptors — at high concentrations zinc blocks the channel at a distinct site from Mg2+, while at low concentrations it potentiates via the GluN2A subunit. Zinc modulates GABA-A receptors (positive allosteric at alpha1, negative at alpha2/3) and glycine receptors. It is required for BDNF synthesis (zinc finger transcription factors) and TrkB signaling. Zinc-dependent enzymes include carbonic anhydrase (CAII, pH regulation), Cu/Zn superoxide dismutase (SOD1, antioxidant defense), and matrix metalloproteinases (synaptic remodeling). In the hippocampus, zinc modulates long-term potentiation (LTP) via CaMKII and MAPK/ERK pathways — the cellular basis of memory formation. Zinc also regulates presynaptic vesicle release.
Risks & Safety
Phenibut
Common
Drowsiness, dizziness, nausea, tolerance with repeated use.
Serious
Physical dependence develops rapidly with daily use. Withdrawal can be severe and dangerous (anxiety, insomnia, psychosis, seizures). Respiratory depression when combined with alcohol or other CNS depressants.
Rare
Hallucinations, severe rebound anxiety, suicidal ideation during withdrawal.
Zinc
Common
Nausea on empty stomach, metallic taste.
Serious
Long-term high-dose use (>40 mg daily) depletes copper, causing anemia and neurological problems.
Rare
Headache, diarrhea, reduced immune function (paradoxically) at very high doses.
Full Profiles
Phenibut →
A GABA-B agonist and alpha-2-delta voltage-gated calcium channel blocker developed in Russia for anxiety, insomnia, and PTSD. It crosses the blood-brain barrier (unlike GABA supplements) and produces potent anxiolytic and social confidence effects. However, it carries significant addiction and withdrawal risks — tolerance develops within days of daily use, and withdrawal can be severe.
Zinc →
An essential trace mineral concentrated in the brain's hippocampus, where it plays a critical role in synaptic transmission and memory formation. Zinc modulates NMDA and GABA receptors, supports BDNF expression, and is required for proper neurotransmitter release. Deficiency is common (estimated 17-25% of the global population) and directly impairs memory, attention, and mood.